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I t is known that colchicine treatment induces specific complexing together 
wi th tubulin cel lular molecules (3) which Inhibits their assembling into micro­
tubules (MT) (7). T h i s exerts a negative effect on mitotic processes and functions 
of numerous cel lular systems 4 (4, 7) . Treatment wi th colchicine in strong dose s 
results in leukocytosis, thrombocytosis and bone-marrow applas ia when blood 
system is concerned (7). Concerning thrombocytes themselves* colchicine i n 
M T destructing doses inhibits s l ight ly the retraction of f ibrin coagulate and the 
l iberat ion of serotonin as well as the aggregation of t h r o m b o c y t e s (12, 14). 
Recent ly , Handagama et a l . (9) have observed thrompbocytopoiesis in­
hibit ion after microtubule destruction by colchicine. 
There are no data in the literature avai lable about the influence of t h e 
changes determined by colchicine on plasm-i Hir>m ')o^ytopУЫ\П ( T P ) ac t i ­
v i ty . T h i s fact as well as the c o n t r o v e r s i e s j> ' ^ i • i o n : datft ci ted insisted us 
to study thrombocytopoiesis* bone-marrow megakaryocytes ( M K C ) and plasma 
T P ac t iv i ty after 3-day low-dose colchicine treatment in r a t s . 
M a t e r i a l a n d methods 
Bll Our observation was carried out on 69 white male rats of Wis ta r breed w i t h 
body weight of 190—200 g and 20 white male recipient mice wi th body weight 
of 25—30 g. Animals were divided into an experimental and a control group. 
Exper imen ta l rats wen treated w i t h colchicine at dosis of 0.5 mg/kg b. w. da i ­
ly intraperi toneally for 3 days but the control animals were administered a 
physiological sal ine. Thrombocyte count was estimated after L i s i c h k o v ' s pha­
sic-contrast method (9) . 75-Selenomethionine ( 7 5 Se-M) incorporation into new­
ly-formed thrombocytes ( i . e. the most significant index of the state of thrombo-
cytopoiesis) as wel l as plashia T P ac t iv i ty was assessed after Penington's method 
in our own modification (Negrev and Ganchev, 15). Bone-marrow megakaryo-
cytogram was estimated after the method of Lev ine et a l . (10) . The data were 
processed by the method of var ia t ion analysis . 
Resu l t s a n d discuss ion 
Our data obtained are presented on fig. 1 and 2 and on table 1. On fig. 1-a 
one can see that 3-day colchicine treatment reduces signif icantly thrombocyte 
coun t i n comparison wi th that of the control animals . 7 5 S e - M incorporation 
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into newly-formed thrombocytes is significantly inhibited, too (fig. 1-b). Bone-
marrow M K C analysis reVeals their diminution not only as a to ta l number 
but also as number in the single stages of their development ( I s t , I I r J , I I I " 1 , 
and especially I V t h stage). P lasma T P ac t iv i ty tested on 20 recipient mice by 
means of two parameters (thrombocyte count and percentage of incorporated 
7 5 Sa-M) under the ihfluence of assessed plasma from animals treated w i t h col­
chicine, on the ofte hand, and wi th saline, oft thfc other hand, is s ta t i s t i ca l ly ! 
significantly higher in eolchicine-treated animals ' plasma than in the contro 
one (f ig. 2-a, b). 
An additional study by using 8- and x-lumicolchicine in 27 male rats does 
not show any significant differences in thrombocyte count and especially in 
the percentage of incorporated 7 5 Se-M in comparison wi th that of saline-tre­
ated controls. Th i s enables saline application as a reliable control when expe­
riments wi th colchicine in this system are concerned. Our data abou 
hrombocyte count reduction are in concordance w i t h those of other 
authors (9) and contrary to Dustin 's results (7). The considerable throrn­
bocytopoiesis inhibition after colchicine treatment indicated main ly by means 
of reduced thrombocyte count, percentage of 7 5 S e - M incorporated into newly-
formed thrombocytes as wel l as of general megakaryocytopoiesis suppression 
proves that both dosis and time duration of the experiment selected b y us are 
inhibitory effective concerning thrornbocytopoiesis. I t stresses t h M M K C count 
decreases significantly ill general and in the single stages, especially in the fourth 
one (by 57.14 per cent). A H differences were statist ically rel iably at p < 0 . ( ) 0 1 . 
I t is known that during the last stage of mi\gakaryo:ytopoiesis the greatest 
number of M K C are liberated followed by the other stages (5) . I t is probably 
the main reason for peripheral thrombocyte count reduction and for diminut ion 
of the percentage of 7 5 Se-M incorporated in thrombocytes! when colchicine-tre­
ated rats are concerned. 
In regard to the increased plasma T P ac t iv i ty ( T P is considered a basic 
specific thrornbocytopoiesis regu la to r—11) after colchicine treatment establi­
shed in our study it has to be noted that the missing l i terature data do not allow 
us to perform a comparative analysis. I t is considered proved that negative feed­
back mechanises participate at T P biogenesis (2) . The reduction of thrombocyte 
count and of the percentage of 7 5 Se-M incorporated into newly-formed thrombo­
cytes as wel l as of M K C number in a l l stages (and especial ly in the th i rd and 
fourth one) are most probably those factors in feed-back mechanisms which in­
duce T P biogenesis increase in our study. 
In our opinion, M T destruction after colchicine treatment results probably 
in supperssion of proliferation as wel l as in inhibi t ion of M K C differentiation. 
Thus it does not influence directly negat ively upon structures responsible for 
T P biogenesis. M K C count reduction, especially in the first stage, can be due 
additionally to an inhibited transition of immediate M K C precursors to 
this cel lular fund that is again a concequence of anti tubular colchicine effect. 
I t is possible that after colchicine treatment other well-known inhib i tory 
and side effects of colchicine participate at the inhibit ion of bone-marrow mega­
karyocytopoiesis and thrornbocytopoiesis, respectively (6, 8, 13). 
We can conclude that our data prove the negative influence of M T destruc­
tion after colchicine treatment on megakaryocytopoiesis and thrornbocytopoi­
esis. However, colchicine treatment does not restrict plasma T P biogenesis but 
induces by means of suppressed megakaryocytopoiesis and thrornbocytopoie­
sis , respectively, its significant increase. 
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g. 1. Thrombocyte number and percentage of incorporated "Selenomethionine ( 7 5 St- M) 
newly-formed thrombocytes after colchicine treatment in rats. 
Л-thrombocytes 
Colchicine — n = 16 
P S — n - 10 
В — percentage of incorporated 7 5 Se-M 
Colchicine — n = 8 
P S — ii - 8 























Fi£. 2. Plasma .thrombocytopoietin activity estimated by the changes of thrombocyte number-
and of percentage of incorporated 7 5 Se-M in newly-formed thrombocytes of recipient mice. 
A — thrombocytes 
Colchicine — treated with plasma from colchicine-injected rats; n = 8. 
P S — treated with control plasma; n = 8. 
В — percentage of incorporated 7 5 Se-M. 
Colchicine — treated with plasma from colchicine-injected rats: n — 10. 
P S — treated with control plasma; n = 10. 
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ВЛИЯНИЕ КОЛХИЦИНА НА ТРЭМБОЦИТОПОЭЗ И ТРОМБОЦИТОПОЭТИНОВ УЮ 
АКТИВНОСТЬ ПЛАЗМЫ У КРЫС 
7. / анчса, //. Нсгрее, Р. Илкова 
ИГЗ Ю М Е 
Изу'иет. 'ч злн?'>ие ко шгцнча как аитнтубулирнын агент на показатели тромбоцито-
поэзз и тромбоцитопоэтинозую активность плазмы у крыс. Колхицин применялся в дозе 
0,5 мг 'кг телесного веса в день, в течение трех дней. 
Устанавливается, что колхицин статистически значимо уменьшает число тромбоцитов, 
процент включенного 7 5 ссленометионина в новообразовавшихся тромбоцитах н клетках 
мегакарио штиного ряда, в особенности в их зрелых формах. Плазменная тромбоцитопоэти-
новая активность, которая определялась на мышах-реципиентах посредством изменения 
числа тромбоцитов и процента включенного 7 5 селенметионина, показывает сильное увели> 
чение у крыс, которым вводился колхицин. 
Авторы полагают, что мнкротубулярная деструкция после введения колхйципа,инги 
бнруя мегакарноцитопоэз и тромбоцнтопоэз у крыс, наверное, по принципу обратной связи, 
стимулирует биогенез тромбоцнтопоэтниа — специфического гуморального регулятора 
тромбоцигопоэза. 
Делается заключение, что мнкротубулярная деструкция не оказывает отрицательного 
воздействия на структуры и механизмы, ответственные за тромбоцитопозтиноеын бпогензе 
при указанной дозе и дтнге:{ыо:гн в з е х м м к з . т - м д п з в и а ц я я о .шге . 
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